Cocrystal Pharma COCP

$ 1.57 4.67%

Annual report 2025
added 03-31-2026

Cocrystal Pharma DIO Ratio 2011-2026 | COCP

Annual DIO Ratio Cocrystal Pharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	-	60.5	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
60.5	60.5	60.5

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Alnylam Pharmaceuticals ALNY	43.5	$ 320.13	-3.98 %	$ 41.9 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.81	0.6 %	$ 1.02 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	$ 1.35	-12.9 %	$ 347 M	USA
	Aquestive Therapeutics AQST	120	$ 4.26	0.47 %	$ 456 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Arcutis Biotherapeutics ARQT	185	$ 24.19	-1.59 %	$ 3.08 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.61	8.05 %	$ 428 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	BioXcel Therapeutics BTAI	1.56 K	$ 1.07	1.9 %	$ 13.1 M	USA
	ChromaDex Corporation CDXC	69.7	-	-0.88 %	$ 598 M	USA